These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38886346)

  • 1. Integrative single-cell and bulk transcriptomes analyses reveals heterogeneity of serine-glycine-one-carbon metabolism with distinct prognoses and therapeutic vulnerabilities in HNSCC.
    Wang L; Yang R; Kong Y; Zhou J; Chen Y; Li R; Chen C; Tang X; Chen X; Xia J; Chen X; Cheng B; Ren X
    Int J Oral Sci; 2024 Jun; 16(1):44. PubMed ID: 38886346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Multiomics Analyses Identify Molecular Subtypes of Head and Neck Squamous Cell Carcinoma with Distinct Therapeutic Vulnerabilities.
    Diao P; Dai Y; Wang A; Bu X; Wang Z; Li J; Wu Y; Jiang H; Wang Y; Cheng J
    Cancer Res; 2024 Sep; 84(18):3101-3117. PubMed ID: 38959352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma.
    Chen Z; Cai H; Ye W; Wu J; Liu J; Xie Y; Feng S; Jin Y; Lv Y; Ye H; Cai C; Cai G
    Front Immunol; 2024; 15():1445472. PubMed ID: 39234254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma.
    Lin W; Xu Y; Gao J; Zhang H; Sun Y; Qiu X; Huang Q; Kong L; Lu JJ
    Front Immunol; 2021; 12():757047. PubMed ID: 34675936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive investigation into the influence of glycosylation on head and neck squamous cell carcinoma and development of a prognostic model for risk assessment and anticipating immunotherapy.
    Ma H; Xiong L; Zhao B; Hahan Z; Wei M; Shi H; Yang S; Ren Q
    Front Immunol; 2024; 15():1364082. PubMed ID: 38562924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constructing heterogeneous single-cell landscape and identifying microenvironment molecular characteristics of primary and lymphatic metastatic head and neck squamous cell carcinoma.
    Zhang J; Liu Y; Xia L; Zhen J; Gao J; Atsushi T
    Comput Biol Med; 2023 Oct; 165():107459. PubMed ID: 37713790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities.
    Dai Y; Wang Z; Xia Y; Li J; Wu Y; Wang Y; Jiang H; Cheng J
    Clin Cancer Res; 2023 Aug; 29(15):2845-2858. PubMed ID: 37192003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
    BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.
    Liu L; Liu Q
    Sci Rep; 2024 Apr; 14(1):9914. PubMed ID: 38688945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two distinct head and neck squamous cell carcinoma subtypes based on fatty acid metabolism-related signatures: Implications for immunotherapy and chemotherapy.
    Zou J; Dai Y; Xu G; Kai Y; Lan L; Zhang J; Wang Y
    Medicine (Baltimore); 2024 Apr; 103(16):e37824. PubMed ID: 38640298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate dehydrogenase B as a metabolism-related marker for immunotherapy in head and neck squamous cell carcinoma.
    Xu X; Pan X; Fan Z; Xia J; Ren X
    Cell Signal; 2024 Aug; 120():111200. PubMed ID: 38719019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel oxidative stress-related gene signature as an indicator of prognosis and immunotherapy responses in HNSCC.
    Li Z; Zheng C; Liu H; Lv J; Wang Y; Zhang K; Kong S; Chen F; Kong Y; Yang X; Cheng Y; Yang Z; Zhang C; Tian Y
    Aging (Albany NY); 2023 Dec; 15(24):14957-14984. PubMed ID: 38157249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and validation of a tumor-infiltrating γδT cell related prognostic gene signature in head and neck squamous cell carcinoma.
    Lu Y; Xiang Z; Wang W; Yun B; Yi C; Zhang M; Xie N; Wang C; Zhuang Z
    Int Immunopharmacol; 2024 May; 132():112054. PubMed ID: 38608477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic model based on Scissor
    Tian G; Zhang J; Bao Y; Li Q; Hou J
    Cell Signal; 2024 Feb; 114():110984. PubMed ID: 38029947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular hierarchy framework based on single-cell/multi-patient sample sequencing reveals metabolic biomarker PYGL as a therapeutic target for HNSCC.
    Guan J; Xu X; Qiu G; He C; Lu X; Wang K; Liu X; Li Y; Ling Z; Tang X; Liang Y; Tao X; Cheng B; Yang B
    J Exp Clin Cancer Res; 2023 Jul; 42(1):162. PubMed ID: 37420300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
    Schinke H; Shi E; Lin Z; Quadt T; Kranz G; Zhou J; Wang H; Hess J; Heuer S; Belka C; Zitzelsberger H; Schumacher U; Genduso S; Riecken K; Gao Y; Wu Z; Reichel CA; Walz C; Canis M; Unger K; Baumeister P; Pan M; Gires O
    Mol Cancer; 2022 Sep; 21(1):178. PubMed ID: 36076232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma.
    Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.